This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Hematology, Other  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

Koga and Aizawa pointed out in their letter that drugs can also induce hypereosinophilia, with a broad spectrum of clinical manifestations. Interestingly, the reactions to drugs causing peripheral eosinophilia are usually the most severe ones. Examples of severe drug reactions associated with increased eosinophil counts are drug rash with eosinophilia and systemic symptoms, toxic epidermal necrolysis, eosinophilic fasciitis (Shulman syndrome), and eosinophilic pneumonia. Eosinophilic fasciitis and eosinophilic pneumonia are often associated,¹ but they are fortunately rare. They can be provoked by a wide variety of medications, most frequently antibiotics and tryptophan derivatives. Toxic epidermal necrolysis encompasses some different severe skin reactions (including the Stevens-Johnson syndrome) due to drugs (from which mortality can be as high as 30%²) that are usually associated with peripheral eosinophilia. It is well-known that patients with human immunodeficiency virus infection are at higher risk of developing toxic epidermal necrolysis, probably because of the . . . [Full Text of this Article]

Giovanni Passalacqua, MD
Genoa, Italy

Carlo Lombardi, MD
Brescia, Italy

RELATED ARTICLES

Iatrogenic Eosinophilia
Takeharu Koga and Hisamichi Aizawa
Arch Intern Med. 2004;164(1):106.
EXTRACT | FULL TEXT  

Eosinophilia and Diseases: Clinical Revision of 1862 Cases
Carlo Lombardi and Giovanni Passalacqua
Arch Intern Med. 2003;163(11):1371-1373.
EXTRACT | FULL TEXT